These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 3923823
1. Use of the agarose gel method to identify and quantitate factor VIII:C inhibitors. Cassidy PG, Triplett DA, LaDuca FM. Am J Clin Pathol; 1985 Jun; 83(6):697-706. PubMed ID: 3923823 [Abstract] [Full Text] [Related]
2. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel. Jorquera JI, Carmona E, Aznar JA, Peiró A, Sánchez-Cuenca JM. Thromb Haemost; 1985 Aug 30; 54(2):377-80. PubMed ID: 3936211 [Abstract] [Full Text] [Related]
3. Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentrates. Coots MC, Glueck HI, Miller MA. Br J Haematol; 1985 Aug 30; 60(4):735-50. PubMed ID: 3927972 [Abstract] [Full Text] [Related]
4. Detection and Measurement of Factor Inhibitors. Kershaw G. Methods Mol Biol; 2017 Aug 30; 1646():295-304. PubMed ID: 28804837 [Abstract] [Full Text] [Related]
5. Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies. Bird P. Br J Haematol; 1975 Feb 30; 29(2):329-40. PubMed ID: 1191553 [Abstract] [Full Text] [Related]
6. Nijmegen-Bethesda assay to measure factor VIII inhibitors. Duncan E, Collecutt M, Street A. Methods Mol Biol; 2013 Feb 30; 992():321-33. PubMed ID: 23546724 [Abstract] [Full Text] [Related]
8. In vitro detection of mild inhibitors to factor VIII in hemophilia. Ewing NP, Kasper CK. Am J Clin Pathol; 1982 Jun 30; 77(6):749-52. PubMed ID: 6807080 [Abstract] [Full Text] [Related]
10. An ELISA assay for the detection of factor VIII antibodies - comparison with the conventional Bethesda assay in a large cohort of haemophilia samples. Shetty S, Ghosh K, Mohanty D. Acta Haematol; 2003 Jun 30; 109(1):18-22. PubMed ID: 12486318 [Abstract] [Full Text] [Related]
14. Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusion. Muhleman AF, Glueck HI, Miller MA, Coots M. Am J Hematol; 1985 Oct 30; 20(2):107-17. PubMed ID: 3929595 [Abstract] [Full Text] [Related]
15. Clinical patterns of hemophilic patients who develop inhibitors. McMillan CW. Prog Clin Biol Res; 1984 Oct 30; 150():31-44. PubMed ID: 6431436 [Abstract] [Full Text] [Related]
16. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency. Gadarowski JJ, Czapek EE, Ontiveros JD, Pedraza JL. Acta Haematol; 1988 Oct 30; 80(3):134-8. PubMed ID: 3143212 [Abstract] [Full Text] [Related]
17. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. Thromb Haemost; 1995 Feb 30; 73(2):247-51. PubMed ID: 7792738 [Abstract] [Full Text] [Related]
20. Letter: Detection and measurement of factor VIII antibodies in an agarose gel: a modified method. Rainsford SG, Hall A. Br J Haematol; 1976 Jun 30; 33(2):309. PubMed ID: 1268100 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]